Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01001039 · ClinicalTrials.gov registry record

Validation of the Facial and Cephalic Pain Inventory

A clinical trial of Sinusitis, sponsored by Greg Davis.

Completed
Registry status
68
Enrollment target
1
Study location

NCT01001039 is a study of Sinusitis that has completed, run by Greg Davis. The registered enrollment target is 68 participants, below the 125-participant average among 12 other Sinusitis trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01001039, a study of Sinusitis, has completed, sponsored by Greg Davis.

COMPLETED
Registry status
68 participants
Enrollment target
1
Study location

Study Summary

This study proposes to develop and validate a new instrument designed to measure facial and nasal discomfort related to chronic sinusitis. The second phase of the study will be to use this instrument to measure correlation with sinus computed tomography (CT) scans.

Conditions Studied

Study Locations (1)

Washington

  • University of Washington Rhinology Clinic - Seattle

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2009-10
Est. Completion 2012-06

Sponsor

Greg Davis

4 total trials

What the Registry Record Tells You About NCT01001039

The ClinicalTrials.gov registry entry for NCT01001039 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 125-participant average among 12 other Sinusitis trials with a reported enrollment target (46% lower). The listed sponsor is Greg Davis, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sinusitis appearing as the primary indexed condition, and to 0 interventions.

NCT01001039 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01001039 about?

NCT01001039 is a clinical study titled "Validation of the Facial and Cephalic Pain Inventory". This study proposes to develop and validate a new instrument designed to measure facial and nasal discomfort related to chronic sinusitis. The second phase of the study will be to use this instrument to measure correlation with sinus computed tomography (CT) scans.

What is the current status of trial NCT01001039?

This trial is currently completed. The enrollment target is 68 participants. The study started on 2009-10. Estimated completion is 2012-06.

What conditions does trial NCT01001039 study?

This clinical trial studies the following conditions: Sinusitis.

Who is sponsoring clinical trial NCT01001039?

This trial is sponsored by Greg Davis, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01001039 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sinusitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.